SCHEMBL11973097

SCHEMBL11973097

O=C(C=Cc1ccc(Br)cc1)c1ccccn1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.77
NPC1 O15118 4/20 0.77
RAB9A P51151 4/20 0.77
KDM4E B2RXH2 4/20 0.77
PKM P14618 3/20 0.77
LMNA P02545 3/20 0.77
MEN1 O00255 2/20 0.68
KMT2A Q03164 2/20 0.68
ALDH1A1 P00352 2/20 0.68
L3MBTL1 Q9Y468 1/20 0.68
SMN1; SMN2 Q16637 2/20 0.62
PLIN1 O60240 1/20 0.58
MAPK1 P28482 1/20 0.58
PLIN5 Q00G26 1/20 0.58
ABHD5 Q8WTS1 1/20 0.58
KRAS P01116 1/20 0.56
CYP1B1 Q16678 2/20 0.55
P4HB P07237 1/20 0.52
MITF O75030 1/20 0.52
TP53 P04637 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11973091 1.00 MAPT (0.77) MAPTNPC1RAB9AKDM4EPKM
SCHEMBL12257967 0.92 MAPT (0.90) MAPTNPC1RAB9AKDM4EPKM
SCHEMBL4400320 0.87 MAPT (1.00) MAPTNPC1RAB9AKDM4EPKM
SCHEMBL977480 0.87 MAPT (1.00) MAPTNPC1RAB9AKDM4EPKM
SCHEMBL1320225 0.86 KDM4E (0.74) MAPTNPC1RAB9AKDM4EPKM
SCHEMBL1320227 0.86 KDM4E (0.74) MAPTNPC1RAB9AKDM4EPKM
SCHEMBL1604280 0.86 MAPT (0.79) MAPTNPC1RAB9AKDM4EPKM
SCHEMBL31436352 0.86 MAPT (0.79) MAPTNPC1RAB9AKDM4EPKM
SCHEMBL1929871 0.84 PKM (0.82) MAPTNPC1RAB9AKDM4EPKM
SCHEMBL6793176 0.84 RAB9A (0.77) MAPTNPC1RAB9AKDM4EPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2626346-B1 BENZO[K]FLUORANTHENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE ELEMENT CONTAINING SAME IDEMITSU KOSAN CO (JP) 2018-01-10 EP disclosed
CN-104258908-B A kind of preparation method of dual different rare-earth fluorescent probe compound 中国工程物理研究院化工材料研究所 2016-08-17 CN disclosed
US-9273002-B2 Benzo[k]fluoranthene derivative and organic electroluminescence device containing the same IDEMITSU KOSAN CO., LTD. (JP) 2016-03-01 US disclosed
EP-2626346-A1 BENZO[K]FLUORANTHENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE ELEMENT CONTAINING SAME Idemitsu Kosan Co., Ltd. (JP) 2013-08-14 EP disclosed
US-20120211743-A1 BENZO[k]FLUORANTHENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE CONTAINING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2012-08-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120211743-A1 BENZO[k]FLUORANTHENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE CONTAINING THE SAME KCNJ2, KCNE1, KCNK2 MAPT 2759/4885NPC1 3587/4885RAB9A 1205/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.